Butenafine: A Viewpoint by Masatoshi Itoh

ISSN： 0012-6667

Source： Drugs, Vol.55, Iss.3, 1998-03, pp. : 413-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Butenafine

By McNeely W. Spencer C.M.

Drugs, Vol. 55, Iss. 3, 1998-03 ,pp. : 405-412

Adis International

Access to resources Recommend Favorite

Butenafine and superficial mycoses: current status

By Singal Archana

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 999-1005

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topic: Cell Cycle Control and Cell Fate)

Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. : 1587-1587

Bentham Science Publishers

Access to resources Recommend Favorite

Butenafine 1% versus Terbinafine 1% in Cream for the Treatment of Tinea Pedis: A Placebo-Controlled, Double-Blind, Comparative Study

By Syed T.A.

Clinical Drug Investigation, Vol. 19, Iss. 6, 2000-06 ,pp. : 393-397

Adis International

Access to resources Recommend Favorite

Nateglinide: A Viewpoint by Riccardo Perfetti

By Perfetti R.

Drugs, Vol. 60, Iss. 3, 2000-09 ,pp. : 616-617

Adis International

Access to resources Recommend Favorite